TrialNCT06531395Phase 2Terminated
A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease
Study sponsor: Kiniksa Pharmaceuticals International, plc · KNSA
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2025-03-06Actual
Enrollment · participants3Actual
Source updated2025-05-21Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.